Delirium, Dementia, Amnestic, Cognitive Disorders  >>  GSK2647544  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK2647544 / GSK
NCT01702467: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers

Completed
1
27
RoW
GSK2647544, Placebo
GlaxoSmithKline
Alzheimer's Disease
05/13
05/13
NCT01978327: GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers

Terminated
1
12
Europe
GSK2647544, drug-drug interaction
GlaxoSmithKline
Alzheimer's Disease
03/14
03/14

Download Options